News
bioMérieux, a world leader in in vitro diagnostics, celebrated the opening of the company’s Molecular Genomic Innovation Center in Philadephia, PA, on September 18th. The new 32,000 sq. ft. facility is home to the xPRO™ Program, which has rapidly changed the landscape of food safety diagnostic capabilities by partnering directly with industry leaders to address unmet needs to streamline operational efficiencies and further public health.
Swipe to discover more
-
First-Half 2024 Results
Marcy l’Etoile (France), September 5th, 2024 – The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on September 4th under the chairmanship of Alexandre Mérieux and approved the consolidated financial statements for the six months ended June 30, 2024. -
The Vital Role of Prevention and Early Detection as Dengue Cases Rise
With cases increasing at an alarming rate over the past two decades, the dengue virus (DENV) has remained a significant threat to global public health. The World Health Organization (WHO) reports that dengue cases skyrocketed from 500,000 to 5.2 million from 2000-2019, and recent reports indicate that cases are on the rise again. As of early 2024, dengue has been classified as a Grade 3 emergency by the WHO, demanding the highest-level response. Although many dengue cases are mild, severe dengue is considered a medical emergency that necessitates intervention as soon as possible. As dengue cases continue to increase, an integrated approach that includes vector control, prevention, and early and accurate diagnosis is critical for mitigation. -
France: the bioMérieux bioindustrial and R&D site of La Balme is diversifying
Two strategic infrastructures were inaugurated this year on the bioMérieux site of La Balme-les-Grottes (Isère, France): a plastic injection unit in June and a new-generation R&D building in September. The global specialist in in vitro diagnostics is continuing its investments in France, aiming to develop new solutions for public health worldwide.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19